These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17699218)

  • 1. Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients.
    Stenvinkel P; Rodríguez-Ayala E; Massy ZA; Qureshi AR; Barany P; Fellström B; Heimburger O; Lindholm B; Alvestrand A
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):281-7. PubMed ID: 17699218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins are associated with a reduced risk of bone fracture in hemodialysis (HD) patients.
    Nichols R; Hopman WM; Morton AR; Harman GJ; Holden RM
    Hemodial Int; 2008 Apr; 12(2):275-9. PubMed ID: 18394063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid.
    Shojaei MH; Djalali M; Siassi F; Khatami MR; Boroumand MA; Eshragian MR
    Iran J Kidney Dis; 2009 Jul; 3(3):141-4. PubMed ID: 19617662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania.
    Segall L; Mardare NG; Ungureanu S; Busuioc M; Nistor I; Enache R; Marian S; Covic A
    Nephrol Dial Transplant; 2009 Aug; 24(8):2536-40. PubMed ID: 19297358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased erythropoietin requirements in maintenance hemodialysis patients with statin therapy.
    Sirken G; Kung SC; Raja R
    ASAIO J; 2003; 49(4):422-5. PubMed ID: 12918584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use is associated with lower inflammation and erythropoietin responsiveness index in hemodialysis patients.
    Koc M; Dogan C; Arinsoy T; Tonbul Z; Ayli D; Cirit M; Sever MS; Yilmaz ME; Unsal A; Suleymanlar G; Ok E; Basci A; Yildiz A
    Hemodial Int; 2011 Jul; 15(3):366-73. PubMed ID: 21507195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study.
    Lee CT; Tsai YC; Ng HY; Su Y; Lee WC; Lee LC; Chiou TT; Liao SC; Hsu KT
    J Ren Nutr; 2009 May; 19(3):220-7. PubMed ID: 19243976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
    Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
    Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid control in diabetic patients in Extremadura (Spain)].
    Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
    Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro- and anti-inflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin.
    Goldstein SL; Leung JC; Silverstein DM
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):979-86. PubMed ID: 17699316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
    Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L
    J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects.
    Chiang CK; Yang SY; Peng YS; Hsu SP; Pai MF; Huang JW; Hung KY; Wu KD
    Am J Nephrol; 2009; 29(5):392-7. PubMed ID: 18974640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index.
    Beberashvili I; Sinuani I; Azar A; Yasur H; Feldman L; Efrati S; Averbukh Z; Weissgarten J
    J Ren Nutr; 2009 May; 19(3):238-47. PubMed ID: 19243974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of ultrapure water on the levels of oxidative stress and inflammation parameters in maintenance hemodialysis patients].
    Zhang Y; Liu J; Tao HQ; Liu ZQ; Tian JW
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1435-7. PubMed ID: 17884796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients.
    Movilli E; Viola BF; Camerini C; Mazzola G; Cancarini GC
    J Ren Nutr; 2009 Mar; 19(2):172-7. PubMed ID: 19218045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
    Maruyama Y; Lindholm B; Stenvinkel P
    J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nutritional status, body composition, inflammation and serum iron on the developement of insulin resistance among patients on long-term hemodialysis.
    Rasić-Milutinović Z; Perunicić G; Pljesa S; Gluvić Z; Ilić M; Stokić E
    Med Pregl; 2007; 60 Suppl 2():33-8. PubMed ID: 18928154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.